Drugs with this side effect
- 4-AP: 4%
- 5-ASA: postmarketing, 0% - 5%
- 5-aminolevulinic acid
- 5-fluorocytosine
- 68Ga
- A77 1726: 9.78% - 10%
- AMD3100
- BCNU: 5.83%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: common
- Cancidas: 0% - 3.1%
- Colimycin M
- D-cycloserine
- Enfuvirtide
- FAMP: 4% - 12%
- FP-CIT: uncommon
- FTY720: 5% - 5.41%
- Fe(III: postmarketing, 6%
- Gd-DTPA
- Gd-EOB-DTPA
- Goserelin: 1.27% - 1-10%
- ICI 182,780: 6.4% - 7.6%
- Implanon: postmarketing
- Insulin
- K779: postmarketing, 1% - 21%
- Kaluril
- L-Dmp: rare
- LY146032: postmarketing, uncommon, 1%
- Leuprorelin
- Lisinopril: postmarketing, uncommon, 0.5% - 2.8%
- Lutalyse
- MDV3100: 0% - 6.6%
- Meropenem anhydrous
- Metrodin
- Nafarelin
- Oestrogen: 1% - 7.5%
- Optison: rare
- PGE2
- Photofrin II: common
- SU5416: 6%
- SonoVue
- Stalevo 50
- Supremon: 2.38%
- TR-700
- Triptorelin
- UDCA
- VACV: 0% - 1%
- abacavir
- abacavir-lamivudine
- acamprosate: 2% - 3%
- acebutolol
- acetazolamide
- acitretin: postmarketing
- acyclovir: 0.8% - 1.2%
- adenosine: 2%
- agomelatine: uncommon
- allopurinol
- almotriptan: 1%
- alprazolam: 2.4% - 7.1%
- amantadine: postmarketing
- amikacin
- amiloride
- amiodarone
- amlexanox: 0.733% - 1.33%
- amlodipine
- amlodipine besylate
- amphotericin B
- amprenavir: 1% - 31%
- amsacrine: 1-10%
- anagrelide: 5.9% - 7%
- anastrozole: 3.56% - 6.95%
- apraclonidine
- aprepitant
- aripiprazole
- arsenic
- arsenic trioxide: common, very common
- articaine
- atenolol
- atomoxetine: postmarketing, 3% - 4%
- atorvastatin
- azelastine: postmarketing
- azithromycin: postmarketing
- aztreonam
- baclofen: rare, 0.654% - 6.7%
- benazepril
- benazeprilat
- benzyl alcohol
- bepridil: 2.46%
- betamethasone dipropionate
- betaxolol: postmarketing, 1.9% - 2.5%
- bexarotene: 6%
- bicalutamide
- bisoprolol
- bleomycin hydrochloride
- boceprevir: common
- bortezomib: 0% - 27.5%
- bosentan
- brimonidine: 0.302% - 0.606%
- brinzolamide: postmarketing
- bromocriptine: postmarketing, rare
- budesonide
- bupivacaine: postmarketing, 0.442% - 1.77%
- buprenorphine: 2%
- bupropion: postmarketing, infrequent, 1% - 2%
- buspirone: 1%
- butorphanol
- cabazitaxel
- cabergoline: 1.19% - 2.6%
- cabozantinib: 0% - 7%
- candesartan
- candesartan cilexetil
- capecitabine: 1% - 21%
- captopril
- carbamazepine: rare, 2%
- carbidopa: 0.8% - 1.1%
- carbinoxamine
- carboplatin
- carboprost
- carnitine: 3% - 12%
- carvedilol: 0.1% - 2%
- cefaclor: postmarketing
- cefepime
- cefpodoxime
- ceftazidime: very rare
- ceftizoxime
- ceftriaxone: 0.1%
- celecoxib
- celiprolol
- cephem
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlorhexidine
- chlorhexidine gluconate
- chlorpheniramine
- chlorthalidone: rare
- cidofovir
- cilazapril
- cilostazol
- cinacalcet: common, 13.8% - 29.4%
- ciprofloxacin: postmarketing, rare
- cisplatin
- citalopram: frequent, 1.4% - 2%
- citric acid
- cladribine: uncommon
- clarithromycin: postmarketing
- clemastine
- clofarabine: common
- clomiphene citrate: postmarketing
- clomipramine: common, 2% - 9%
- clonidine
- clopidogrel: uncommon
- clozapine: postmarketing
- colestyramine
- conjugated estrogens
- copolymer 1
- cortisol
- crizotinib
- cyanocobalamin
- cyclizine
- cyclobenzaprine
- cyclophosphamide: postmarketing
- cyproheptadine
- cytarabine: 3%
- dacarbazine
- dalteparin
- danazol
- darunavir
- deferoxamine: very rare
- delamanid
- delavirdine
- deprenyl: frequent
- desmopressin
- desvenlafaxine: 2%
- dexamethasone
- diatrizoate
- diazoxide
- dichlorphenamide
- diclofenac: very rare, postmarketing, 0% - 20%
- diflunisal
- dihydrocodeine: uncommon
- dihydroergotamine: postmarketing, 2%
- diltiazem: 1% - 2%
- dimercaptosuccinic acid
- diphenhydramine
- dipyridamole: 1.3%
- disopyramide
- docetaxel: 1% - 15%
- dofetilide
- dolasetron
- donepezil: frequent
- dorzolamide: postmarketing
- dothiepin
- doxapram
- doxazosin: postmarketing, 0% - 1.7%
- doxepin: infrequent
- doxercalciferol
- doxorubicin: common, 0% - 11.7%
- doxycycline
- duloxetine: postmarketing, common, frequent, 1% - 4%
- efavirenz: postmarketing
- eletriptan: 3% - 4%
- eltrombopag: 3%
- elvitegravir: uncommon
- emtricitabine
- epinephrine
- eprosartan
- ergotamine
- eribulin
- ertapenem
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: postmarketing
- etidronate: postmarketing
- etodolac: postmarketing
- etravirine
- everolimus: 5%
- exemestane: postmarketing
- ezetimibe: postmarketing, uncommon
- famciclovir: 0% - 2.6%
- famotidine
- febuxostat
- felbamate: 3.5%
- felodipine
- fenofibrate
- fentanyl: very rare, postmarketing, 1.8% - 2%
- ferumoxytol: postmarketing
- flecainide
- fluconazole: postmarketing
- fludarabine: 4% - 12%
- flumazenil
- fluorescein: postmarketing, uncommon
- fluoxetine: frequent
- flurbiprofen
- fluvastatin: very rare, postmarketing
- fluvoxamine: postmarketing, infrequent, 3%
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: 0% - 4.4%
- fospropofol
- fotemustine
- frovatriptan
- furosemide: rare
- gabapentin: infrequent, frequent
- gadobenate dimeglumine
- gadobutrol
- gadodiamide: postmarketing
- gadofosveset
- gadolinium: 0.1% - 2.22%
- gadopentetate
- gadoteridol: 0.42%
- gadoversetamide: 1.2% - 2.22%
- galantamine: infrequent, frequent
- ganciclovir: 8%
- gatifloxacin: postmarketing
- gemcitabine: 0% - 26%
- gemfibrozil: 0.4% - 0.9%
- glibenclamide
- gliclazide
- glimepiride
- glipizide
- granisetron
- griseofulvin
- guanfacine: postmarketing
- guanidinium
- halobetasol
- halofantrine
- hepatitis B vaccines: rare
- histamine
- hydralazine
- hydrochlorothiazide
- hydrocodone
- hydromorphone
- hydroxybutyrate: 1% - 3%
- ibandronate
- ibuprofen
- icodextrin
- ifosfamide: postmarketing
- iloperidone
- imatinib: common, 0% - 12.1%
- imipramine: common
- imiquimod: uncommon, 0.4% - 1.7%
- indacaterol: uncommon
- indapamide
- indinavir
- indomethacin
- iodixanol
- iohexol
- iopamidol
- iopromide: 0.2%
- iotrolan
- ioversol
- ioxilan
- ipratropium bromide
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- irinotecan: postmarketing
- iron sucrose
- isocarboxazid
- isomannide
- isosorbide-5-mononitrate
- isradipine
- itraconazole: postmarketing
- ixabepilone
- kanamycin
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine: postmarketing
- labetalol: 0% - 1%
- lacosamide: 4% - 8%
- lamivudine: very rare, postmarketing
- lamotrigine: frequent
- lanreotide
- lansoprazole: 0% - 3.23%
- leflunomide: postmarketing, common, 1% - 4%
- lenalidomide: common
- lercanidipine
- letrozole
- leuprorelin acetate: 0% - 3%
- levetiracetam: 1.9% - 2%
- levobunolol
- levodopa/carbidopa: 0.8%
- lidocaine
- lindane: postmarketing
- linezolid
- lomefloxacin
- lomitapide
- loratadine
- lormetazepam
- losartan
- lovastatin: postmarketing
- loxapine
- maprotiline
- maraviroc: 3% - 5%
- mecamylamine
- meclofenamate: postmarketing
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing
- mefenamic acid
- mefloquine: postmarketing
- megestrol
- melatonin
- meloxicam
- memantine: infrequent
- mepivacaine
- meprobamate
- meropenem
- mesna
- metformin
- methazolamide
- methimazole
- methyclothiazide
- methyldopa
- methylergometrine: postmarketing
- methylphenidate: postmarketing, 1.2%
- methylprednisolone
- methysergide
- metolazone
- metoprolol: postmarketing, rare, uncommon
- metronidazole: very rare, postmarketing
- mexiletine: 2% - 3.8%
- mianserin: very rare
- midazolam
- midodrine: common, 4.5% - 18.3%
- miglustat: 0% - 7.5%
- milnacipran: 2% - 3%
- minocycline
- mirtazapine: postmarketing, frequent
- mitotane
- mitoxantrone
- moclobemide
- modafinil: postmarketing, 1%
- mometasone
- mometasone furoate
- montelukast: postmarketing
- morphine
- moxifloxacin
- mycophenolate mofetil: 15.2% - 20.8%
- mycophenolic acid: 18% - 20.8%
- nabilone
- nabumetone: 0.8%
- nadolol
- nalidixic acid
- nalmefene
- naloxone
- naltrexone
- naproxen
- naratriptan: frequent, 1% - 7%
- natamycin
- nebivolol
- nefazodone
- nelarabine: 0% - 15%
- nelfinavir
- nevirapine: postmarketing
- niacin: postmarketing
- nicardipine: 0.192% - 0.7%
- nicorandil: uncommon
- nicotine
- nifedipine
- nilotinib: uncommon, common
- nilutamide: 3%
- nisoldipine
- nitrofurantoin
- nitroglycerin
- norfloxacin: postmarketing
- nortriptyline
- ofloxacin: 1%
- olanzapine: frequent
- olsalazine: postmarketing
- omeprazole: postmarketing, uncommon
- ondansetron: 1.65%
- orlistat: uncommon
- oxaliplatin: common, very common, 0% - 92%
- oxaprozin
- oxazepam
- oxybutynin
- oxycodone
- paclitaxel: postmarketing
- paliperidone
- palonosetron
- pamidronate: common
- pantoprazole: postmarketing
- paricalcitol
- paroxetine: postmarketing, rare, common, 0% - 5.9%
- pazopanib
- penciclovir: postmarketing, 0% - 2.6%
- pentamidine
- pentazocine
- pentosan polysulfate
- pentostatin
- perampanel: 0% - 2%
- pergolide: frequent, 1.6%
- perhexiline
- perindopril
- perindopril erbumine
- phenelzine
- phentolamine
- phenylephrine
- phenytoin: 0% - 4.4%
- phosphate
- pilocarpine
- pimecrolimus
- pindolol: 1% - 6%
- piroxicam
- pixantrone
- polymyxin B
- polythiazide
- ponatinib
- posaconazole
- pramipexole: 1.4%
- pravastatin: 0.9% - 3.2%
- prazosin
- prednicarbate
- prednisolone
- prednisolone acetate
- prednisone
- pregabalin: frequent, 2.2%
- prilocaine
- procarbazine
- progesterone: postmarketing
- propafenone: postmarketing
- propofol
- propranolol
- propylthiouracil
- prostacyclin: 1% - 12%
- pyridoxine
- quetiapine: 0% - 3%
- quinapril
- quinaprilat
- rabeprazole
- raltegravir
- ramipril
- ramiprilat
- ranolazine: postmarketing
- rapamycin: 4%
- rasagiline: 2% - 5%
- reboxetine: postmarketing, 3.4%
- regadenoson: common
- remifentanil: 0% - 1.14%
- repaglinide: 1% - 2%
- retigabine: 2% - 5%
- retinoic acid: postmarketing, common, 0% - 22%
- ribavirin: 5%
- rifabutin
- riluzole
- rimonabant
- risedronate
- risperidone: infrequent
- ritonavir: 0% - 6%
- rivastigmine: frequent
- rizatriptan: 3% - 4%
- rofecoxib
- ropinirole: 3% - 5%
- ropivacaine: 1.4% - 25.4%
- rosuvastatin
- rotigotine: 5%
- roxithromycin
- salbutamol: postmarketing
- salmeterol
- salmon calcitonin acetate: postmarketing, uncommon
- samarium: 2.01%
- saquinavir: common
- sertraline: postmarketing, rare, common, 2% - 3%
- sibutramine
- sildenafil: 1% - 5%
- simvastatin: postmarketing
- sodium: postmarketing
- sodium cromoglycate
- sodium ferric gluconate: 6%
- sodium iothalamate
- sotalol: 1% - 4%
- sparfloxacin
- stavudine: common
- streptomycin
- strontium ranelate: postmarketing
- sulindac
- sumatriptan: infrequent, common, 1% - 5%
- sunitinib
- tacrolimus: 0% - 40%
- tadalafil
- tamoxifen: 4.69% - 6.95%
- tamsulosin: 0.4%
- tapentadol
- teduglutide
- telavancin: uncommon
- telithromycin
- telmisartan
- temozolomide: common, 0.633% - 9.49%
- tenofovir disoproxil fumarate
- terazosin: 0.8% - 2.9%
- terbinafine: very rare, postmarketing, uncommon
- terbutaline
- tesamorelin: 1.5% - 4.8%
- testolactone
- testosterone: postmarketing, uncommon
- testosterone undecanoate
- thalidomide: 0% - 15.6%
- thiazide
- thiotepa
- thymidine: postmarketing
- tiagabine: 4%
- ticagrelor
- timolol: 0.6%
- tinidazole
- tiotropium
- tizanidine: postmarketing, frequent
- tobramycin
- tofacitinib
- tolcapone: 3%
- topiramate: postmarketing, rare, 0% - 51%
- topotecan: common
- trabectedin
- tramadol: postmarketing, rare, uncommon
- trandolapril
- trandolaprilat
- tranylcypromine
- trazodone: postmarketing, 0% - 1.4%
- treprostinil
- triamcinolone
- triamcinolone acetonide
- triazolam
- trimethadione
- trovafloxacin
- v 1784: postmarketing, common, 0% - 11.1%
- valdecoxib
- valganciclovir: 5% - 6%
- valproate: 0.9% - 7.1%
- valsartan
- vandetanib
- vardenafil
- venlafaxine: postmarketing, common, 2% - 3%
- verapamil: postmarketing, 1%
- vernakalant: common, 6.9%
- vigabatrin: common, 2% - 7%
- vilazodone: 3%
- vinblastine
- vincristine
- vinflunine
- vinorelbine: 0% - 10%
- voriconazole: common
- warfarin
- zaleplon: 3%
- ziconotide
- zidovudine: postmarketing, rare, 6%
- zidovudine/lamivudine
- ziprasidone: uncommon, frequent, 0% - 2%
- zoledronic acid: uncommon, common, 0% - 2%
- zolmitriptan: 5% - 10%
- zolpidem: infrequent, 1%
- zonisamide: infrequent, 4%
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|